Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Apellis Pharmaceuticals Inc (NASDAQ:APLS) Releases Favorable Results From Phase 3 PEGASUS…
Atara Biotherapeutics Inc (NASDAQ:ATRA) Enrolls The First Patient In Its ATA188…
Kitov Pharma Ltd (NASDAQ:KTOV) CONSENSI® Approved In The US For Osteoarthritis…
Aeterna Zentaris Inc. (NASDAQ:AEZS) Enters Strategic Distribution Agreement For Marketing Of…
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Reveals Additional Data From Valoctocogene Roxaparvovec Gene…
Finance
SelectQuote, Inc. (NYSE:SLQT) takes the front stage
Bulls finally looking to break the COVID shackles
Bulls ready to take over S&P 500
VIX finally shows signs of stabilization
Markets aren’t falling apart (SPY, AMZN, SLV, COST, KR, NFLX, APRN)
Tech News
ISWH and the Rebirth of the Crypto Cycle
Home
Biotech
Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Apellis Pharmaceuticals Inc (NASDAQ:APLS) Releases Favorable Results From Phase 3 PEGASUS study As A Candidate For Treating paroxysmal Nocturnal Hemoglobinuria
Ward Sport
-
July 9, 2020
Atara Biotherapeutics Inc (NASDAQ:ATRA) Enrolls The First Patient In Its ATA188 Allogeneic T-cell Therapy Study For Treating Multiple Sclerosis
Kitov Pharma Ltd (NASDAQ:KTOV) CONSENSI® Approved In The US For Osteoarthritis Pain And Hypertension
Aeterna Zentaris Inc. (NASDAQ:AEZS) Enters Strategic Distribution Agreement For Marketing Of Macimorelin In Middle East
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Reveals Additional Data From Valoctocogene Roxaparvovec Gene Therapy Study
NanoViricides Inc (NYSEAMERICAN:NNVC) Files Its Q3 2020 Report With The Securities...
Ward Sport
-
July 8, 2020
0
Protagonist Therapeutics Inc (NASDAQ:PTGX) Announces Orphan Drug Designation For PTG-300 From...
Gavins Felicity
-
July 8, 2020
0
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) Finalizes The Enrollment Of 36 Subjects In...
Matt Wade
-
July 8, 2020
0
Ovid Therapeutics Inc (NASDAQ:OVID) Awarded Rare Pediatric Disease Designation For OV101...
Gavins Felicity
-
July 8, 2020
0
Lineage Cell Therapeutics Inc (NYSEAMERICAN:LCTX) Reveals Interim Findings From Phase 1/2a...
Kate Hudson
-
July 8, 2020
0
Atara Biotherapeutics Inc (NASDAQ:ATRA) Reveals That Underwriters Have Exercised Option To...
Gavins Felicity
-
July 7, 2020
0
Clovis Oncology Inc (NASDAQ:CLVS) And Alkermes Plc (NASDAQ:ALKS) Announce Positive Pre-clinical...
Ward Sport
-
July 7, 2020
0
Jaguar Health Inc (NASDAQ:JAGX) Achieves Favorable Findings In Preclinical Study Involving...
Kate Hudson
-
July 7, 2020
0
Agenus Inc (NASDAQ:AGEN) Strikes Balstilimab and Zalifrelimab Licensing Deal With Betta...
Kate Hudson
-
July 7, 2020
0
Acasti Pharma Inc (NASDAQ:ACST) Receives The FDA’s Written Response Regarding Request...
Gavins Felicity
-
July 7, 2020
0
1
2
3
...
17
Page 1 of 17
.td-post-views{ display: none !important; }
